We are pleased to release the latest edition of the Clinical Spotlight highlighting two exciting BSC technologies: the SYNERGY Stent System and the Lotus Valve System. As your peers, it is our pleasure to share the scientific story behind SYNERGY providing you with insights into the pre-clinical data and our robust Investigator-Sponsored Research (ISR) program, updates on the EVOLVE Short DAPT study and a comprehensive video review from our principal investigators. This newsletter also showcases the Lotus Valve, with an update on the RESPRISE III study, commentary from the PIs, and the latest clinical data presentations from PCR London Valves 2015 and TCT 2015.
We truly hope this content resonates and has a positive impact for your clinical practice.
Craig A. Thompson, MD
Senior Vice President and Chief Medical Officer
Keith D. Dawkins, MD
Executive Vice President and Global Chief Medical Officer
Dr. Dean Kereiakes, principal investigator of EVOLVE II, details the SYNERGY Stent design, the need for bioabsorbable polymer technology, and the current clinical data.
The Role of Investigator-Sponsored Research in the SYNERGY Clinical Program
CMO Dr. Craig Thompson and Dr. de la Torre Hernandez comment on Investigator-Sponsored Research regarding SYNERGY. Also see results from Dr. de la Torre Hernandez’s OCT Healing Assessment of SYNERGY and review the current ISR Program for the SYNERGY Stent.
Evaluation of reduced DAPT duration with next generation bioabsorbable polymer DES
As principal investigator of the recently approved EVOLVE Short DAPT trial, Dr. Mauri will be evaluating a novel, bioabsorbable polymer DES, SYNERGY, with 3 month DAPT in patients at high risk for bleeding. Read Dr. Mauri’s EVOLVE Short DAPT announcement and view the EVOLVE Short DAPT Study Design.
How does SYNERGY compare with other stents regarding endothelial cell coverage, endothelial cell function, and thrombogenicity? Click here to see the pre-clinical data.
First US Head-to-Head Lotus Valve vs. CoreValve Study Update
REPRISE III PI’s Dr. Feldman and Dr. Reardon share insight on recent and upcoming milestones for the Lotus Valve. View the latest Lotus Valve clinical data presentations and review the REPRISE III Study Design.